Development

INSIGHTS ON DRUG DEVELOPMENT

Tips And Tricks Addressing PCR Pain Points
qPCR workflows are vital but prone to common errors. Improve the precision and reliability of your gene expression data by mastering key strategies to overcome frequent experimental pitfalls.
Understand Fluorescence And How It Enhances Scientific Exploration
Deepen your understanding of fluorescence for research, and gain valuable insight into how to select appropriate fluorophores and fluorescent proteins for your experiments.
5 Key Considerations For Companies Outsourcing Process Development
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success
By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.

Optimization And Scale-Up Of A Plasmid DNA Production Process
9/30/2025

Optimizing pDNA production in E. coli requires strategic media selection and scale-up planning. Explore a study that identifies ideal conditions for high-yield manufacturing.
The Top Tech Transfer Risks At Multi-Site CDMOs
3/31/2026

Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.
Analyzing Biological Drug Effects In 3D
10/24/2025

Explore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.
Multiplex Imaging
3/24/2025

Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.
Transformative Innovation: Advancing Drug Development Using In Silico Modeling
3/4/2026

Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.

Gain Human-Relevant Insights With Patient-Derived Assay-Ready Organoids

3D organoids offer enhanced physiological relevance and are ready to use from cryopreserved vials. Discover how they can streamline your research with high-quality and comprehensive support.
Lyophilization And Sterile Manufacturing

The addition of global Sterile Fill-Finish and extensive lyophilization capabilities ensures that we are able to build on our enviable reputation and deliver on our promise of delivering life-changing therapies to patients worldwide.
Solutions For Aggregate And Fragment Analyses

Learn more about important considerations in peptides and SEC column separation and a SEC column technology solution.
Sterile Drug Product

Accelerate sterile injectable development with expert support, advanced facilities, and tailored solutions for complex APIs — from formulation through commercialization across small molecules and biologics.
Payload-Linker

Learn how high‑potency infrastructure, strong impurity control, and scalable payload‑linker capabilities help teams manage risk, maintain purity, and advance toward clinical‑stage ADC development.